Shattuck Labs, Inc. — Director's Dealing 2023

Jan 28, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Shattuck Labs, Inc. (STTK)
CIK: 0001680367
Period of Report: 2023-01-25

Reporting Person: Pandite Arundathy N. (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-25	Common Stock	A	37875	$0.00	Acquired	175792	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-01-25	Stock Option (Right to Buy)	$3.57	A	69750	Acquired	2033-01-25	Common Stock (69750)	Direct

Footnotes

F1: Consists of 37,875 restricted stock units, which will vest in four equal annual installments beginning on January 25, 2024, subject to the Reporting Person's continued service to the Issuer.

F2: This option represents a right to purchase a total of 69,750 shares of the Issuer's common stock, one quarter of which will vest on January 25, 2024, with the remaining three quarters vesting in equal monthly installments through January 25, 2027, subject to the Reporting Person's continued service to the Issuer.